Hamilbra
The FDA approved Hemlibra to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (Source: Business Wire)
Health and Fitness

FDA Approves New treatment to Prevent Bleeding in Certain Patients with Hemophilia A

by on

More in Health and Fitness:

Silver Spring, Maryland—(ENEWSPF)—November 16, 2017

Proud member of LION Publishers

By: Angela Stark

Hamilbra
The FDA approved Hemlibra to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (Source: Business Wire)

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

“Reducing the frequency or preventing bleeding episodes…

Articles published under the "eNews Park Forest" byline may be press releases or news prepared by official representatives of organizations.

Facebook X Instagram

Most read stories this week

Take a Survey

ARCHIVES